Cadence Minerals Prioritizes Azteca Restart at Amapá as Annual Results Show Progress on Execution Pathway

Cadence Minerals’ 2025 annual results are really about one big pivot: stop trying to do everything at Amapá at once, and get the smaller Azteca restart over the line first. For retail investors, that is the whole story. It lowers the upfront capital burden, sharpens the operational focus, and gives Cadence its clearest route yet to first operating cash flow.

That said, this is not a clean victory lap. Cadence is still pre-production, still reliant on external funding, and the timetable for Azteca has slipped beyond the earlier end-June 2026 target. So the tone here is better than last year, but it is still a delivery story rather than a finished turnaround.

Cadence Minerals annual results 2025: Azteca restart becomes the main investment case

The company has formally split the Amapá story into two stages. First comes Azteca, a lower-cost restart using already mined or partly processed material on site. After that comes the larger Amapá DR Project, which targets direct reduction grade iron ore concentrate – a higher-grade product used in cleaner steelmaking.

In plain English, Cadence has decided to take the smaller, more achievable step first. That is a sensible move. Trying to fund a full-scale redevelopment in one jump would have been a stretch for a company of this size, especially in a choppy commodity and capital markets backdrop.

The company says Azteca now has a defined production plan, identified feed material and a secured funding structure. Post period, it also received the Preliminary Environmental Licence and Installation Licence, which allow refurbishment works to proceed.

That is real progress. The market tends to reward projects when they move from broad ambition to specific execution milestones, and Cadence is clearly trying to get into that lane.

Amapá Azteca restart funding, licences and commissioning delays – what matters most now

Azteca is designed to produce approximately 380,000 tonnes per annum of around 65% Fe concentrate. The estimated pre-production capex is approximately US$3.5 million, with estimated operating costs of approximately US$37/dmt FOB. FOB means free on board – essentially the cost up to loading the product for shipment, not including the ocean freight to the customer.

The key funding piece is a US$4.6 million prepayment offtake facility. An offtake prepayment is basically a future buyer advancing money now in return for product later. Cadence’s direct contribution was limited to the Tranche 1 amount of US$391,000, or approximately 8.5% of the facility, with the balance provided by the offtake partner.

That is a positive development because it reduces the immediate need for fresh equity. It does not remove dilution risk altogether, but it does show management is trying to fund the restart with something smarter than simply issuing more shares every time the cash balance gets tight.

The snag is timing. Cadence explicitly says the commissioning timetable has moved beyond the earlier targeted end-June 2026 date, and a revised date is not disclosed. That matters because delays push back first cash flow and increase the chance of further funding pressure.

The remaining critical path is very clear now:

• complete refurbishment works;
• finish commissioning;
• receive the Operating Licence required before commercial operations and shipments can begin.

So yes, the regulatory fog has lifted a bit. But Azteca is still not producing, and until it is, Cadence remains in the expensive middle ground between plan and payoff.

Cadence Minerals financial results 2025: lower losses, stronger net assets, but still pre-production

Key figure	2025	2024
Total comprehensive loss	£1.71 million	£3.33 million
Basic EPS	(0.526)p	(1.651)p
Net assets	£18.62 million	£17.21 million
Cash and cash equivalents	£1.06 million	£0.66 million
Borrowings	£89,000	£755,000
Public equity portfolio value	£6,000	£473,000

The loss improved materially, falling to £1.71 million from £3.33 million. That was helped mainly by lower realised and unrealised losses on listed investments, not by operating profits. So this is an accounting improvement rather than proof of a self-funding business.

Net assets rose to £18.62 million, while borrowings dropped sharply to just £89,000. Cash also improved to £1.06 million. Those are good signs, especially the debt reduction.

But the company also issued 119,660,000 new ordinary shares during the year, raising gross proceeds of £3.04 million before costs. That is the trade-off. Cadence preserved momentum at Amapá, but shareholders paid for part of that progress through dilution.

Another notable point: the public equity portfolio has effectively been sold down to almost nothing. That tells you management is concentrating capital on Amapá rather than keeping a broader investment portfolio running in the background.

Sonora Lithium arbitration funding: useful optionality, but not an operating recovery

Cadence still holds a 30% interest in the Sonora Lithium Project, but there was no operational progress during the year. The project remains tied up in concession cancellation and legal proceedings in Mexico.

The useful update is that post period, Cadence secured non-recourse arbitration funding to support claims under the UK-Mexico BIT. Non-recourse means the funding is tied to the case outcome rather than being standard operating debt. That gives Cadence a funded route to pursue legal recovery without piling the same burden onto its balance sheet.

Still, investors should treat Sonora as a legal asset, not a near-term production asset. Timing and outcome are uncertain, and the company says exactly that.

Going concern warning, shareholder dilution and why retail investors should not ignore the small print

This is the bit that matters most if you own the shares. The auditors highlighted a material uncertainty related to going concern. In simple terms, the accounts are still prepared on the basis that the company continues operating, but there is significant uncertainty because Cadence remains dependent on future funding and on Azteca eventually generating cash.

The company had £1.06 million of cash at year end, and directors say downside scenarios such as further commissioning delays, slower ramp-up or lower cash generation would require additional funding. That could mean more equity issuance if non-dilutive options are not available on acceptable terms.

So although the strategic reset makes sense, this is still a high-risk AIM development play. The project is better defined than it was, but not yet de-risked enough to call comfortable.

My take on Cadence Minerals shares after the 2025 annual results

On balance, I think this RNS is cautiously positive. Cadence has made a practical decision to focus on the part of Amapá that can get moving fastest, it has secured a funding structure for Azteca, it has cleared two important post-period permitting hurdles, and it has cut borrowings heavily.

The negative side is just as clear. Production has still not started, the commissioning target has slipped, the company remains reliant on external funding, and the auditor’s going concern warning is not cosmetic. It is telling you that execution now matters more than presentations, studies or strategy slides.

For retail investors, the next markers are obvious: refurbishment progress, commissioning, and most importantly the Operating Licence. If Azteca reaches commercial operations, the whole Cadence equity story starts to look more credible. If it slips again, dilution risk probably comes back into sharper focus.

So this annual results statement does not make Cadence safe. But it does make the route to value creation clearer than it was before, and for a small-cap resources company, that is not a trivial step.